Feed to the latest filings at the SEC
Date Filed : Oct 22, 2024
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
InhibikaseTherapeutics, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
45719W205
(CUSIP Number)
October 21, 2024
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box todesignate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
The remainder of this cover page shall be filled out for a reporting persons initial filing on this formwith respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the SecuritiesExchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 45719W205
NAMES OF REPORTING PERSONS
Perceptive Advisors LLC
CHECK THE APPROPRIATE BOX IF AMEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☐
SEC USE ONLY
CITIZENSHIP OR PLACE OFORGANIZATION
Delaware
NUMBER OF
SHARES BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
SOLE VOTING POWER
0
SHARED VOTING POWER
6,799,944
SOLE DISPOSITIVE POWER
SHARED DISPOSITIVE POWER
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
CHECK BOX IF THE AGGREGATEAMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
PERCENT OF CLASS REPRESENTED BYAMOUNT IN ROW 9
9.99%
TYPE OF REPORTING PERSON (SEEINSTRUCTIONS)
IA
Joseph Edelman
United States ofAmerica
IN
Perceptive Life Sciences Master Fund, Ltd.
CaymanIslands
CO
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in thisstatement is true, complete and correct.
Date: October 22, 2024
Name: Joseph Edelman
Title: Managing Member
/s/ Joseph Edelman
JOSEPH EDELMAN